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Common respiratory viruses cause seasonal epidemics in sequential patterns. The underlying
mechanisms for this pattern have been debated for some time. For influenza, contenders include
temperature, humidity, and vitamin D levels. While such seasonal drivers may be sufficient to explain
midwinter peaking it is unclear if other respiratory viruses peaking in spring, summer, or fall have
individual environmental drivers. Here we present a dynamic model of interacting diseases, in an
effort to explain observed seasonal patterns without requiring multiple seasonal drivers. Our model
extends the classical SIRS-model to include multiple diseases that interact via a short-lasting, non-
specific immunity component. This temporal protection is triggered by exposure to any epidemic
disease and lasts only a couple of weeks. We show that the inhibiting disease-interaction allows
recurrent epidemic behaviour without any seasonal driving. In the presence of a single seasonal
driver our model parsimoniously predicts epidemic patterns such as sequentially occurring epidemic
diseases. We also present a two-disease simulation reproducing multiple features observed in time
series of parainfluenza strains PIV-3 and biennial PIV-1 epidemic patterns. Complex epidemic
patterns of seasonal diseases may be explained by non-specific innate or cloub cell (T-cell) mediated
immune responses that result in interaction between unrelated respiratory epidemic diseases.
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I. INTRODUCTION
Mysteriously, each year respiratory viruses cause epi-
demics that peak in predictable months during spring,
summer, fall and winter [1–6]. The fact that the North-
ern and Southern hemisphere displays mirror image pat-
terns of timing suggest that epidemic timing is deter-
mined by seasonal environmental driver(s). This has
been known probably since the beginning of virology
in the 1930s, but the phenomenon is still in search of
an explanation. Various authors have suggested that
winter-seasonality in for example influenza is explained
by a seasonal driver such as cold weather, low humid-
ity or low vitamin D levels [1, 2, 7–10]. However, in
order for such mechanisms to explain spring, summer,
and autumn seasonality one would need to imagine a
different seasonal driver for each season – perhaps for
each virus – not an appealing or parsimonious hypothesis.
Rather, the repeated annual patterns suggest that some-
how epidemic diseases can repel each other and await
their turn. Such a mechanism of epidemic interference
has been proposed by Rohani [11, 14, 16] who demon-
strated that by introducing short-lasting, non-specific im-
munity into classical dynamic childhood disease models
one can find parameters for which one epidemic would ex-
clude another. Yet most mathematical models of disease-
∗ G. G. J. and F. U. contributed equally to this work.
disease interactions published to this date explore the ef-
fects of Ab-mediated specific, life long cross immunity
[12, 13, 15, 17]. When short-lasting immune mechanisms
are considered it is typically in a single disease context
to explain phenomena like multi-wave diseases [18–22] or
to provide an evolutionary bottleneck for influenza evo-
lution [23]. Thus, models have yet to explored the possi-
bilities of inter-epidemic dynamics in multiple-pathogen
models that include terms of short-lasting non-specific
immunity. Here we address this intriguing question anew,
proposing a dynamic disease model form that can the-
oretically address this type of inter-species interaction.
Our model work is motivated by the ever increasing ev-
idence for short-lasting acquired non-specific immunity
[22, 24–27].Prominently, the mechanism has been directly
demonstrated in controlled laboratory experiments with
influenza A infections that prevented subsequent infec-
tion with influenza B for 6 to 12 weeks in mice [27].
We explore theoretically whether it is possible to ex-
plain the phenomenon of recurrent multiple epidemics
with predictable (and different) seasonality by introduc-
ing short-term non-specific immunity into the classical
type of SIRS modelling and choosing parameter values
consistent with known mechanisms such as innate immu-
nity. This way we allow for individuals infected with a
disease to be temporarily unavailable for infection with a
second disease, and then re-enter the susceptible pool for
the second disease after a few weeks. To test the perfor-
mance of our model against observed epidemic patterns,
we apply the model form to real-life epidemiological time
series data of PIV-1 and PIV-3 in the US. We find that
our model can reproduce the observed signature patterns
of seasonal diseases assuming only a single environmental
driver and one type of short-lasting non-specific immu-
nity.
Before introducing the model in detail we emphasise
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Figure 1. Model from the perspective of individual hosts.
Each host is in either the I, R, or S state with respect to
each disease, and either has non-specific immunity (Gon) or
not (Goff ). The green arrows represent exposure of host 1 to
disease 1 due to contact with the infected host 2. Infections
(S → I) require exposure to the disease, but are prevented if
the the host has non-specific immunity Gon (as indicated by
the red links).
that there are multiple biological motivations for short
non-specific immunity. While it may represent a uni-
versally active innate immunity [24], any other less spe-
cific short-term immune defences that affect a class of
diseases [27, 28] are valid motivations as well. We will
not explicitly distinguish between these motivations in
the following, as our model is general enough to repre-
sent any of them. As a result, it must be decided on an
individual basis whether sub-types or strains of viruses
should be considered distinct diseases in the context of
this model or not. The crucial criteria are that diseases
should not confer significant long-term cross-immunity
to each other and allow for reinfection. For example,
in the case of influenza A, we would consider the differ-
ent sub-types (H3N2,H1N1) to be distinct diseases, since
infection with one does not typically confer long-term im-
munity against another. The strains of a sub-type how-
ever would be considered the same disease here, to allow
reinfection every couple of years. Under that represen-
tation influenza ”waning” specific immunity become an
abstraction of antigenic drift and cluster transitions. [29]
With respect to PIV (parainfluenza virus) and RSV (res-
piratory syncytial virus) on the other hand, the waning
immunity represents an actual loss of effective specific
immunity in the host. [30, 31]
II. MODEL AND METHODS
Our model is based on the traditional SIRS-model[32]
with a homogeneous, fully mixed host population. We
extend this model to multiple diseases and add a new
feature, the effect of a non-specific immune protection,
which is short-lived. We think of this additional kind of
immunity as a way of modelling either an increased effi-
ciency of the innate immune system observed by [27] or as
short-lived cross-immunisation between similar, but not
identical, diseases. All events, like contact between hosts
or recovery from a disease, are modelled on the basis of
transition rates. In agent-based simulations with host-
populations of finite size this leads to stochastic dynam-
ics, while the behaviour for very large host-populations
can be approximated using differential equations. We
will describe the model from the perspective of individ-
ual hosts, which is shown schematically in figure 1.
SIRS: The traditional SIRS-model can be sum-
marised as follows: Each host can be Susceptible,
Infectious, or Removed. The transmission of diseases
is modelled using a contact rate. If the contacted host is
susceptible, it becomes infectious (S → I). During one
period of being infectious, a host will on average contact
R0 randomly chosen hosts. This is commonly referred
to as the basic reproduction number. The average time
a hosts stays infectious until entering the removed state
(I → R) is TI . Similarly, a removed host becomes sus-
ceptible again (R→ S) after an average time of TR.
Multiple diseases: To describe multiple diseases
spreading in the same host population, we track whether
the host is Susceptible, Infectious, or Removed with re-
spect to each disease independently (see disease 1 and 2
in Fig. 1). The R state therefore represents a disease
specific immunity.
We then add a non-specific immunity, which is either
active (Gon), or inactive (Goff ). If it is active, the host
is protected against infection with any disease, even if it
is in the S state with respect to some of them. The non-
specific immunity is activated (Goff → Gon) every time
a host comes into contact with any of the diseases, also
if infection is prevented by specific immunity (host is in
R state with respect to the disease). This assumption al-
lows maximal interaction between diseases. The average
time the non-specific immunity stays active is TG (G for
General Immunity).
Since the assumption of short-term but 100% effec-
tive non-specific immunity is not necessarily realistic, we
conducted simulations with non-specific immunity that
is twice as long, but not fully protective (50%). We
achieved both qualitatively and quantitatively similar re-
sults (data not shown).
Model parameters: The model has 4 parameters,
three of which are independent. Throughout the paper
we keep as many parameters as possible fixed to the same
value.
R0: Basic reproduction number. Mean number of trans-
mission attempts over the course of one infection.
Expected number of secondary cases in a com-
pletely susceptible population. R0 = 2.5 in case
studies without seasonal variation. Case studies
with a seasonal driver use R0(t) = 2+c ·sin(2pit/τ),
with c = 0.1 or c = 0.2 and τ = 1year.
TI : Mean duration of infectiousness. Since scaling all
durations TX by a common factor has no dynamic
effect, we set TI = 1 without loss of generality. For
common respiratory diseases, TI = 1 represents≈ 6
3days. All simulations are conducted with TI = 1,
without exception. All other durations are specified
in multiples of TI .
TR: Mean duration of disease specific immunity. Unless
stated otherwise TR = 100.
TG: Mean duration of short non-specific immunity TG ≤
6. See individual figure for specific values.
R0, TI and TR can be disease specific parameters. Unless
stated otherwise, they are chosen to be identical for all
diseases.
The mean duration of specific immunity is rather short
in most simulations (few years). This reflects the fact
that immunity is often incomplete in viruses such as
PIV[30] and RSV[31], which allows for frequent reinfec-
tion. In influenza on the other hand, the effective dura-
tion of specific immunity is shortened by the antigenic
evolution of influenza[29].
Simulation details: All simulations discussed in this
paper were initialised with an almost exclusively suscepti-
ble population. Stochastic agent-based simulations with
a finite number of hosts were performed using a Gillespie
algorithm. The population consists of 500 000 suscepti-
ble hosts and a single ’exterior host’, who is infectious
with all diseases and never recovers. The ’exterior host’
represents external sources of infections, which has the
side-effect of preventing stochastic extinction.
Similarly, the deterministic simulations contain an
’external reservoir’ of always infectious hosts which is
500 000 times smaller than the simulated population.
The external reservoir dramatically reduces transient
time, i.e. the time before a stable pattern emerges. In
simulations with a seasonal driver the external reservoir
is 200 000 times smaller than the simulated population.
This increase of external infection severely reduces the
transient time before the epidemic limit-cycle is reached.
The deterministic rate equations are solved using the
Euler method with a time-step of 0.001TI . To break the
symmetry between diseases with identical dynamical pa-
rameters, we initialise the deterministic simulations with
a one thousandth of the population being infectious with
disease one, and two thousandths of the population being
infectious with disease two, etc.
We have not systematically explored the robustness of
the dynamics to initial conditions. However, we also have
not observed sensitivity to the choice of initial-conditions,
except for a small parameter region of bi-stability marked
in Fig. 2c.
III. RESULTS
First, we investigate the simplest case where inter-
actions can be observed: Two diseases with identical
dynamical parameters, without changing environmental
factors. Fig. 2a&b shows two case studies with different
durations of average of non-specific immunity (TG), for
which we observe qualitatively different behaviour. In the
case of very short non-specific immunity (TG = 0.1), both
diseases approach an endemic equilibrium state as shown
in Fig. 2a. This resembles the well known behaviour
without non-specific immunity (traditional SIRS). The
other case, shown in Fig. 2b, considers a longer dura-
tion of non-specific immunity (TG = 4, corresponding to
about 24 days for a disease with a 6-day infectious pe-
riod). Here we observe a repeated pattern of distinct epi-
demics, alternating between the two diseases. The agent-
based and deterministic (infinite population size) simu-
lations exhibit the same qualitative behaviour. These
examples show that introduction of non-specific immu-
nity can lead to recurrent alternating epidemics, a fea-
ture that unmodified deterministic SIRS models do not
exhibit[33]. These case studies show that the non-specific
immunity needs to exceed a certain average duration to
maintain recurrent epidemics.
In Fig. 2c we further investigate the phenomenon by
measuring the amplitude of the recurring epidemics for
specific choices of R0 and duration of non-specific immu-
nity TG. Since realistic durations for the non-specific
immunity are short (2 − 4 weeks), we only show the
behaviour for TG < 15, which corresponds to up to 3
months, if the infectious period is 6 days long. In this
range, recurrent epidemics are observed for most reason-
able values of R0 and TG. More specifically, recurrent
epidemics are only absent if the interaction between the
two diseases is very weak (short non-specific immunity
time) or R0 is close to 1.
The time series in Fig. 2a&b show the transient be-
haviour of simulations. Much longer simulations, such as
those underlying Fig. 2c show that the behaviour indeed
converges to stable periodic attractors.
III.1. Recurring alternating epidemics
For a given parameter set, we can numerically find the
endemic fixed point and then perform a linear stability
analysis. We have done this on a fine grid over the param-
eter spaces shown in Fig. 2c & 3c and found supercritical
Hopf-bifurcations, where the stable (endemic) fixed-point
becomes unstable and emits a stable (epidemic) limit-
cycle. The bifurcation lines are shown as dashed white
lines in Fig. 2C & 3C. The amplitudes measured in de-
terministic simulations match well with the calculated
bifurcation lines.
III.2. Diseases with different dynamical parameters
In the previous section we established the emergence
of recurrent epidemics for two diseases for a wide range
of dynamical parameters, which were set to be identical
for both diseases. A natural concern is, whether this be-
haviour is robust to variations of dynamical parameters
between the two diseases. Next we explore the dynamics
of two diseases with differing parameters for transmis-
sibility (R0 changes, while TI = 1 remains unchanged)
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Figure 2. Dynamics with two diseases with mean specific
immunity duration of TR = 100TI . (a&b): Case studies
with R0 = 2.5. Continuous lines show stochastic agent-based
simulations with 500000 hosts. Dotted lines show one of the
diseases in deterministic simulations. (a): Short non-specific
immunity TG = 0.1TI , leads to endemic equilibrium state.
(b): Longer non-specific immunity TG = 4TI , leads to re-
current alternating epidemics. (c): Spikiness of epidemic be-
haviour. For each data point the deterministic simulation
of two diseases is run for a period of 11000TI . The maxi-
mum and minimum of infectious hosts (Imax, Imin) during
the last 1000TI is measured and log10
Imax
Imin
is plotted. The
white dashed line was obtained by linear stability-analysis and
marks the bifurcation line between stable endemic fixed point
and epidemic limit-cycles. The black dotted line encloses an
area with two stable epidemic limit-cycles (the plotted color
corresponds to the one with larger amplitude).
and duration of specific immunity (TR). We approach
this question by varying the disease specific R0,d and the
duration of specific immunity TR,d of the two disease in
opposite directions:
R0,d=1 = R0 + ∆R0 R0,d=2 = R0 −∆R0 (1)
TR,d=1 = TR + ∆TR TR,d=2 = TR −∆TR (2)
We choose R0 = 2.5 and TR = 100TI as base values
and set the average duration of non-specific immunity to
TG = 6TI . As in the previous section, we will first ex-
amine two case studies, which are shown in Fig. 3a&b.
The exact choice of parameters is shown in Fig. 3c. In
the first case study R0 and TR are both increased for one
disease and decreased for the other, which leads to a dy-
namics of alternating recurrent epidemics, similar to the
pattern observed for diseases with identical parameters.
In the second case study the two parameters are varied
in opposite directions, R0 is increased, while TR is de-
creased for one disease and vice-versa for the other. The
epidemic pattern still shows recurring epidemics, how-
ever, the two disease exhibit a different number of peaks
per period and less pronounced peaks.
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Figure 3. Dynamics with two diseases with different dy-
namical parameters. The transmissibility R0 and specific im-
munity duration TR differ between diseases by ±∆R0 and
±∆T0 from their respective mean R0 = 2.5 and TR = 100TI .
TG = 6TI remain unchanged, and TI is the same for both
diseases. (a&b): Case studies. Stochastic simulations are
shown in solid lines. Dashed line shows the deterministic re-
sults for one of the diseases in b. ∆T0 and ∆R0 are marked in
c in the corresponding line color. (c): Spikiness of epidemics.
See Fig. 2 for details on measurement.
We then explore this phenomenon in more detail (fig-
ure 3c). In general larger R0 increases the frequency of
recurrent epidemics in our model, while larger TR reduce
the frequency. The diagonal region with high amplitude
(red) in the centre of Fig. 3c signifies parameter vari-
ations, with little change in peak frequency, where the
differences in R0 and TR compensate each other. This
produces alternating recurrent epidemics as seen in 3a.
Parallel to this central region are two secondary areas
with high amplitudes, which represent parameter sets,
where one peaks twice as often as the other, as seen in
the second case study. If the periods don’t match, the
sustained alternating epidemics are replaced by a more
varied temporal pattern with lower amplitudes.
We find that the epidemic behaviour is robust to mod-
erate differences in both R0 and TR, especially when the
variations are such that the natural periods of recurrence
of the two diseases are similar or approximately multiples
of each other.
III.3. Multiple Diseases
After exploring the case of two diseases in detail, we
will briefly show examples with more than two diseases.
The model is defined for an arbitrary number of diseases,
so it’s straight forward to extend our investigations. The
number of possible host-states however, grows exponen-
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Figure 4. More than 2 diseases in deterministic simulations
with TG = 6TI . The basic reproduction number is R0 =
2.5 except for panel (d), where R0 = 5. The mean specific
immunity time is TR = 100TI .
tially with the number of diseases, which quickly makes
the simulations unfeasible in the deterministic limit of in-
finitely many agents. ’Individual host’-based simulations
could be a way around this issue, but it would not be
possible to study the model without noise. Determinis-
tic simulations for up to 5 diseases are shown in Fig 4.
With increasing number of diseases the temporal pattern
becomes more varied. In general only systems with a lim-
ited number of diseases can sustain alternating recurrent
epidemics.
We observe that larger values of both R0 and TR allow
for narrower epidemic spikes, which increases the num-
ber of supported diseases without breaking the pattern of
alternating epidemics. Narrower epidemic spikes are nec-
essary to sustain many alternating recurrent epidemics,
because the non-specific immunity suppresses simultane-
ous outbreaks of different diseases, thus limiting the frac-
tion of time available to the individual disease.
III.4. Seasonality
A common method for incorporating seasonal factors
in SIRS -models is by making R0 time-dependent. Con-
sequently, this section will discuss an extension of our
model with an annually varying basic reproduction num-
ber R0(t) = 2 + 0.1 · sin(2pit/τ), where τ specifies the
length of a year in multiples of TI .
Fig. 5 shows different 3-disease patterns produced by
our model for different choices of the duration of non-
specific immunity TG. In this context we can think of
TG as a control-parameter for the strength of interaction
between the diseases. It is worth noting that a similar
set of patterns can be found by varying TR, or the mean-
value or amplitude of R0(t). We use the same dynamical
parameters for all three diseases and subject them to the
same seasonal driving via R0(t). Similar to the multitude
of observed epidemic patterns in nature, our model pro-
duces a variety of dynamics, based on the exact parame-
ter choices. In the following we will relate some patterns
observed in nature to the different panels in Fig. 5:
In the case of concurrently spreading influenza A sub-
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Figure 5. Deterministic simulations with three disease-
systems with different strength of non-specific immunity TG.
All dynamical parameters except for TG are equal in all panels
and for all diseases: R0(t) = 2+0.1·sin(2pit/120), TR = 250TI .
(a) With weak interaction (low values of TG), the seasonal
driver dominates the dynamics. (b&c) With intermediate
interaction-strength the seasonal driver controls the periodic-
ity, but the epidemic peaks are separated in time. (d) Strong
interaction prevents completion of distinct epidemics during
every year. In combination with the seasonal driver this leads
to a loss of the annual periodicity.
types (H3N2 and H1N1) whose concurrently dominant
strains have different antigenic profiles, we see that the
dynamics is dominated by the seasonal driver, with few
differences between disease variants. Unsurprisingly, this
is reproduced in panel a, where the non-specific immunity
is short, which implies weak interaction.
Some types of PIV on the other hand, tend to peak
at different times than others. PIV-3 typically peaks in
early summer, while PIV-1, 2 and 4 are more common
in the fall. Panel B shows a similar pattern between
diseases with medium duration of non-specific immunity.
One disease peaks separately from the other two, which
remain synchronised.
Panel C shows the behaviour with non-specific immu-
nity that lasts long enough to spread the peaks of all
three diseases over more than half a year, even though
they have the same dynamical parameters and depend
on the same seasonal driver. Finally, in panel D, the in-
teraction between diseases is so strong that the epidemic
behaviour does not converge to a pattern with a one year
periodicity.
III.5. Modelling observed PIV-1&3 seasonal
pattern
For PIV-1 and PIV-3 a particularly interesting pat-
tern is typically observed. The activity of PIV-3 be-
tween epidemic peaks is consistently lower every second
year, which coincides with the biennial outbreaks of PIV-
1 [4, 5]. It has been suggested that this correlation is
caused by an interaction between the two diseases[4].
We found that our model can reproduce multiple fea-
tures of the described dynamics, with a seasonally vary-
ing R0 and a longer specific immunity-time for PIV-1
than for PIV-3 (see Fig. 6 for detailed information on
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Figure 6. Upper panel: Seasonal variant of the deterministic model with two diseases, resembling PIV-1 and PIV-3. The
basic reproduction number is varied seasonally using a sine function R0(t) = 2 + 0.2 · sin(2pit/(60TI)). The average immunity
time is TG = 4TI and the specific immunity times are TR,PIV 1 = 170TI and TR,PIV 1 = 120TI . Rescaled to a year, this implies
an infectious period of ≈ 6 days, on average ≈ 24 days of non-specific immunity, and specific immunity that lasts on average
2 years (PIV-3) and ≈ 2.8 years (PIV-1). The external reservoir of constantly infectious hosts is 1/200 000 of the population
size. The annual maxima of R0 are aligned with March 1st in the lower panel. Lower panel: Percentage of positive tests for
PIV-1 and PIV-3 serotypes in the US reported to NREVSS from July 1990 to June 2004. This data was extracted from Fry et
al.[4]. Due to the low image quality of the original, the estimated extraction uncertainty is (±10days,±0.2%).
parameters). The direct comparison between simulated
and observed prevalence in Fig. 6 shows that the model
reproduces many features of the observed dynamics, such
as: (1) PIV-3 peaks annually, while PIV-1 peaks every
second year. (2) In years with a PIV-1 epidemics, the val-
ley of PIV-3 activity is significantly deeper. (3) The next
PIV-3 epidemics is delayed by ≈ 3 months in years with
a PIV-1 epidemic. (4) PIV-1 epidemics ascend for many
months and end abruptly, while the individual PIV-3
peaks are more symmetrical. If the simulation is exe-
cuted with zero – or very low levels of – non-specific im-
munity, but otherwise identical parameters, the system
converges to a limit-cycle in which both diseases have
epidemic outbreaks every year.
IV. DISCUSSION
Many respiratory viral diseases cause seasonal epi-
demics in predictable months. It is well known that
epidemics of different diseases spike at different times
of the year, but it is not clear why. Typical discus-
sions of epidemic patterns point to a variety of seasonal
drivers[1, 2, 7–10]. It is not clear, however, why these
would have a different influence on otherwise similar res-
piratory pathogens causing these epidemics. Here we
have demonstrated that a simple SIRS-model with a sin-
gle seasonal driver can predict different seasonal patterns
even for diseases with identical dynamical parameters
(figure 5), provided that these diseases interact through a
short-lasting non-specific immune response in their hosts.
At an organism level, innate immunity, or cross-
immunity between specific viral strains, may have many
different causes[22, 24–27]. Our non-specific immunity
mechanism could be interpreted as any of these or even a
combination. It is, however, worth noting that the effect
should be short-lasting, i.e. much shorter than the ef-
fect of antibody mediated (pathogen specific) immunity,
but also not too short. In figure 5a it is observed that
if the average duration of the non-specific immunity is
as short as the average infectious period, the interaction
between diseases is too weak to overcome the effect of
the environmental driver. This seems to indicate, that
the observed effect would not occur just because of be-
havioural changes caused by the sickness, such as staying
home from work.
This paper is not the first to make a theoretical inves-
tigation of how non-specific immunity may change the
epidemic patterns of diseases. Some works have explored
a similar concept using a coalescence, following the in-
fection of one disease, in which hosts are neither infec-
tious nor susceptible to any diseases[11, 14, 16]. However,
these models are mostly inspired by phenomena related
to childhood diseases, which leads to some fundamental
differences in the underlying single-disease dynamics. In
particular, the pathogen-specific immunity is assumed to
last forever, making it necessary to explicitly keep track
of birth and death processes. In addition, these models
have, to the best of our knowledge, not yet been used to
directly address the question of seasonal ordering.
We have found that our model is able to predict re-
current epidemic oscillations, even in the absence of sea-
sonal driving. This is an interesting result in itself, as
it is well known that epidemic limit cycles don’t exist
for any parameters in the classical SIRS model. In the
figures 2 and 3, we have investigated these recurrent epi-
demic patterns using a combination of local linear sta-
bility analysis and direct simulations. The reason why
non-specific immunity can break the stability of the en-
demic fixed point in our model is that one disease post-
pones the spread of others, thereby increasing the number
of hosts without specific immunity to these temporar-
ily suppressed diseases. In turn, this causes larger epi-
demics once the non-specific immunity wears off, thus
leading to epidemic peaks, as opposed to stable levels in-
fectious hosts. While these results are interesting, they
are not particularly surprising since similar phenomena
have been observed in related models with short term
non-specific immunity[11, 14, 16], as well as epidemic
models with life long cross immunities[12, 13, 15, 17].
Finally we have shown an example of how our model
is able to reproduce a number of qualitative features in
7the complex epidemic pattern of PIV-1 and PIV-3 ob-
served in the period between 1990 and 2004 in the United
States. This strengthens the hypothesis proposed by Fry
et. al[4], that this pattern is caused by interference be-
tween the epidemics of the two diseases. With this result
in mind, we suggest that disease-disease interactions me-
diated by non-specific immunity (innate immunity) may
have a larger effect epidemic patterns than previously
suspected.
DATA, CODE AND MATERIALS
The model is completely reproducible from the descrip-
tion in the main text, and all parameters are made avail-
able in the figure captions.
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